DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation is a research paper published in eLife (2023). On theSindex it has a DataRank of 0.889. It has been cited 36 times, with 35 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.542
From this paper's citation signal
Citation Network Contribution
0.347
From 25 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 35 citers.
National Cancer Institute
Grant: F30CA265277
National Cancer Institute
Grant: R01CA163649
National Cancer Institute
Grant: U54CA274329
National Cancer Institute
Grant: R21CA251151
National Institute of General Medical Sciences
Grant: R35GM126908
National Cancer Institute
Grant: R01CA270234
NCI NIH HHS
Grant: T32 CA009476
National Institutes of Health
Grant: 1U54CA274329-01
Pancreatic Cancer ARTNet Center
National Institutes of Health
Grant: 1R35GM126908-01
RNA polymerase II elongation control
National Institutes of Health
Grant: 5F30CA265277-04
Targeting pyrimidine biosynthesis in pancreatic ductal adenocarcinoma
National Institutes of Health
Grant: 1R21CA251151-01
PROTACs for pancreatic cancer therapy
National Institutes of Health
Grant: 1R01CA270234-01
Molecular Basis of ME2-mediated Tumor Suppression in Pancreatic Cancer
National Institutes of Health
Grant: 2R01CA163649-06A1
Targeting MUC1-Mediated Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer
Fields of Study
MeSH Terms
Keywords